Effectiveness of Corticosteroid Monotherapy for Dyspnea Relief in Patients with Terminal Cancer.

Related Articles Effectiveness of Corticosteroid Monotherapy for Dyspnea Relief in Patients with Terminal Cancer. J Pain Palliat Care Pharmacother. 2017 Jun;31(2):148-153 Authors: Maeda T, Hayakawa T Abstract Dyspnea is a common symptom in patients with cancer, particularly those with late-stage terminal disease. It markedly affects terminal cancer patients, reducing their quality of life. Reduced quality of life also affects survival; therefore, dyspnea is a prognostic factor. However, the role of corticosteroids, which often are used to alleviate dyspnea, has not been sufficiently validated. In this study, we retrospectively investigated whether corticosteroid monotherapy was effective for dyspnea palliation. The effectiveness rate…
Origen: Effectiveness of Corticosteroid Monotherapy for Dyspnea Relief in Patients with Terminal Cancer. – PubMed